Indo US Bio-Tech appoints Bhagat & Associates as statutory auditor
Indo US Bio-Tech Limited appointed M/s. Bhagat & Associates as statutory auditor effective June 15, 2026, following the resignation of M/s. Gautam N Associates. The resignation was due to administrative and operational restructuring of audit assignments. The new auditor's term runs until the conclusion of the next General Meeting, subject to shareholder approval.

*this image is generated using AI for illustrative purposes only.
Indo US Bio-Tech Limited has appointed M/s. Bhagat & Associates as its new statutory auditor following the resignation of M/s. Gautam N Associates, effective June 15, 2026. The change in auditor was driven by the company's administrative and operational restructuring of audit assignments, according to a regulatory filing.
The Board of Directors approved the appointment of M/s. Bhagat & Associates at its meeting held on June 16, 2026, based on the recommendation of the Audit Committee. The new auditor's term runs from the date of Board approval until the conclusion of the next General Meeting, subject to shareholder approval. The firm, registered with the Institute of Chartered Accountants of India, holds Firm Registration Number 101100W and has no relationship with the company's directors or key managerial personnel.
M/s. Gautam N Associates resigned from the position of Statutory Auditor effective June 15, 2026. The firm, which was originally appointed on September 30, 2020, had its term scheduled to expire at the conclusion of the 26th Annual General Meeting following a Board-approved re-appointment in October 2025. The resignation letter confirmed there were no concerns or efforts made by the auditor prior to stepping down, nor were there any limitations on the scope of audit or lack of information provided by management.
The outgoing auditor's latest report was the Independent Auditors' Report for the year ended March 31, 2026, submitted on May 29, 2026. M/s. Gautam N Associates stated they will provide necessary professional clearances to the incoming auditors to ensure compliance with the Companies Act, 2013. The company has confirmed that the information provided regarding the resignation and appointment is complete and correct.
Auditor Details
| Particulars | Details |
|---|---|
| Outgoing Auditor | M/s. Gautam N Associates, Chartered Accountants |
| Resignation Date | 15-06-2026 |
| Reason for Resignation | Administrative and operational restructuring of audit assignments |
| New Auditor | M/s. Bhagat & Associates, Chartered Accountants |
| Firm Registration Number | 101100W |
| Date of Appointment | 15-06-2026 |
| Term | Until the conclusion of the next General Meeting |
Historical Stock Returns for Indo Us Bio-Tech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.97% | -3.56% | -6.51% | -22.04% | -56.23% | -70.39% |
Will the appointment of M/s. Bhagat & Associates lead to any changes in the company's audit approach or reporting standards?
How will shareholders vote on the new auditor's appointment at the upcoming General Meeting?
What specific operational restructuring measures prompted the resignation of the previous auditor?

































